Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Diabetes Obes Metab. 2018 Nov 11;21(3):575–583. doi: 10.1111/dom.13556

Table 3:

Relationships between Tubular Markers and Intrarenal Hemodynamic Function in Adults without Type 1 Diabetes

Variables Non-diabetic Controls
GFRINULIN ERPFPAH RVR PGLO RA RE
NGAL* (per ng/ml) r: −0.18, p=0.13 −0.19, p=0.10 0.20, p=0.09 −0.06, p=0.63 0.19, p=0.10 0.21, p=0.07
β±SE**: −13.35±6.17, p=0.03 −88.97±38.72, p=0.02 30.59±11.05, p=0.007 −0.79±0.97, p=0.42 1382.91±579.88, p=0.02 116.72±73.79, p=0.12
B2M* (per ng/ml) r: −0.49, p<0.0001 −0.42, p=0.0003 0.34, p=0.003 −0.22, p=0.06 0.30, p=0.01 0.18, p=0.13
β±SE**: −31.74±6.83, p<0.0001 −160.66±45.57, p=0.0008 39.34±13.60, p=0.005 −3.06±1.14, p=0.009 1925.51±708.20, p=0.008 2.09±92.98, p=0.98
OPN (per ng/ml) r: 0.13, p=0.27 −0.05, p=0.69 −0.05, p=0.67 0.06, p=0.64 −0.12, p=0.33 0.21, p=0.08
β±SE**: 0.05±0.04, p=0.23 −0.01±0.28, p=0.98 −0.07±0.08, p=0.42 0.00±0.00, p=0.47 −4.73±4.17, p=0.26 0.52±0.52, p=0.32
UMOD (per ng/ml) r: 0.20, p=0.09 0.21, p=0.08 −0.24, p=0.05 −0.18, p=0.13 −0.20, p=0.09 −0.06, p=0.62
β±SE**: 0.05±0.03, p=0.07 0.30±0.19, p=0.12 −0.10±0.05, p=0.06 −0.01±0.00, p=0.16 −4.34±2.85, p=0.13 −0.04±0.36, p=0.91
*

Natural log transformed

**

Adjusted for age, sex, SBP and LDL

r: Correlation coefficient; β: Beta coefficient; SE: Standard error; NGAL: Neutrophil gelatinase-associated lipocalin; B2M: β-microglobulin; OPM: Osteopontin; UMOD: Uromodulin; GFR: Glomerular filtration rate; ERPF: Effective renal plasma flow; MAP: RVR: Renal vascular resistance; PGLO: Glomerular pressure; RA: Afferent arteriolar resistance; RE: Efferent arteriolar resistance.